Fresenius dumps its $4.3B Akorn buyout, and a 'legal battle royale' could come nextadmin 23rd April 2018 Uncategorised 0
A year after inking its $4.3 billion Akorn buyout agreement, Fresenius plans to scrap the deal, citing “material breaches of FDA data integrity requirements.” Akorn, though, isn’t having it, and analysts are skeptical, too. The upshot? A “legal battle royale” could be on the horizon.
More: Fresenius dumps its .3B Akorn buyout, and a 'legal battle royale' could come next